CareDx (CDNA) vs Molina Healthcare (MOH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
CareDx (CDNA) has outperformed Molina Healthcare (MOH) over the past year, gaining 307.5% versus a gain of 40.1%. Over five years, CDNA leads with a +65.2% price change compared with -32.2% for MOH. Molina Healthcare is the larger company by market cap ($10.36 billion vs $3.68 billion), about 2.8 times the size, while CareDx is growing revenue faster (+13.8% vs +11.7%).
On valuation, Molina Healthcare trades at a lower forward P/E (20.5x vs 44.7x for CareDx). Molina Healthcare converts more of its revenue into profit, with a net margin of 1.0% versus -5.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CDNA | MOH |
|---|---|---|
| Share price | $70.00 | $198.39 |
| Market cap | $3.68B | $10.36B |
| 1-day change | -2.67% | -2.43% |
| YTD return | +271.55% | +14.32% |
| 1-year return | +307.45% | +40.15% |
| 5-year return | +65.21% | -32.16% |
| P/E ratio (TTM) | 29.54 | — |
| Forward P/E | 44.75 | 20.54 |
| EPS (TTM) | $2.37 | $-0.68 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $379.81M | $45.43B |
| Revenue growth (YoY) | +13.79% | +11.75% |
| Net income (latest FY) | $-21.35M | $472.00M |
| Gross margin | — | 13.07% |
| Operating margin | -8.10% | 1.72% |
| Net margin | -5.62% | 1.04% |
| 52-week high | $90.87 | $244.89 |
| 52-week low | $15.56 | $121.06 |
| Distance from 52-week high | -22.97% | -18.99% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +34.90% | +10.66% |
| Average volume | 1.30M | 798.73K |
| Shares outstanding | 52.54M | 52.20M |
| Employees | 761 | 19,000 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Molina Healthcare is about 2.8 times larger than CareDx by market value ($10.36B vs $3.68B).
- CDNA has outperformed MOH by 267.3 percentage points over the past year.
- Molina Healthcare is more profitable, keeping 1.0 cents of every revenue dollar as net income versus -5.6 cents for CareDx.
About CareDx
CDNA stock →CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.
Health Care · Medical Specialities · 761 employees
About Molina Healthcare
MOH stock →Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States.
Health Care · Medical Specialities · 19,000 employees
CDNA vs MOH FAQ
Which is bigger, CareDx or Molina Healthcare?
Molina Healthcare (MOH) is larger, with a market capitalization of $10.36B compared with $3.68B for CareDx (CDNA).
Which stock has performed better over the past year, CDNA or MOH?
CDNA returned +307.45% over the past 12 months, compared with +40.15% for MOH (price return, excluding dividends). Past performance does not predict future results.
Are CareDx and Molina Healthcare in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.